Biocon Limited annual operating income for fiscal 2026 was ₹17.2 billion, an increase of 5.9% from ₹16.3 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Operating Income (EBIT) | ₹17.2B | ₹16.3B | ₹14.3B | ₹16.3B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Operating Income (EBIT) | ₹3.0B | ₹5.1B | ₹3.2B | ₹3.6B | ₹3.1B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More BIOCON metrics: Revenue · Gross Profit · Net Income · EPS · Free Cash Flow
All BIOCON financial statements → Interactive BIOCON charts →
About TickerBase · Data methodology & sources · Privacy · Terms